Literature DB >> 9743205

Comparison of the frequencies of arginines in heavy chain CDR3 of antibodies expressed in the primary B-cell repertoires of autoimmune-prone and normal mice.

M R Krishnan1, T N Marion.   

Abstract

Because the pathogenesis of anti-DNA Ab in SLE is correlated to Ab specificity for native DNA (dsDNA), understanding how such specificity is generated is important. The VH structures of most autoimmune anti-DNA antibodies include at least one arginine in VH-CDR3; moreover, antibody specificity for dsDNA can be correlated to the relative position of arginines in VH-CDR3. The coding sequences for most VH-CDR3 arginines among the anti-DNA MoAbs we have studied to date appeared to have been encoded by sequences generated during V-D-J recombination and would have been expressed in the primary B-cell repertoire. The frequency at which arginine codons are generated during V-D-J recombination therefore could potentially influence the frequency at which DNA-specific B cells are generated in the primary B-cell repertoire. The present study was undertaken to determine whether a higher percentage of B cells in the primary, preautoimmune repertoire of autoimmune-prone (NZB x NZW)F1 mice have immunoglobulin heavy chains with at least one VH-CDR3 arginine compared to B cells in the primary, preimmune repertoire of non-autoimmune-prone BALB/c mice. The present results indicate that mature B cells in preautoimmune (NZB x NZW)F1 mice, whether specific for DNA or not, are no more likely to have heavy chains with VH-CDR3 arginines than are B cells in BALB/c mice. The high frequency of recurrence of VH-CDR3 arginines among autoimmune anti-DNA in (NZB x NZW)F1 mice would appear to derive from the selective oligoclonal expansion of selected B cells that express such structures.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9743205     DOI: 10.1046/j.1365-3083.1998.00426.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  11 in total

1.  Predominant role for activation-induced cytidine deaminase in generating IgG anti-nucleosomal antibodies of murine SLE.

Authors:  Thiago Detanico; Wenzhong Guo; Lawrence J Wysocki
Journal:  J Autoimmun       Date:  2015-01-26       Impact factor: 7.094

2.  Molecular analysis of anti-N-propionyl Neisseria meningitidis group B polysaccharide monoclonal antibodies.

Authors:  Gregory R Moe; Apurva Dave; Dan M Granoff
Journal:  Mol Immunol       Date:  2005-09-02       Impact factor: 4.407

3.  Anti-nuclear antibody reactivity in lupus may be partly hard-wired into the primary B-cell repertoire.

Authors:  Sooghee Chang; Liu Yang; Young Mee Moon; Young Gyu Cho; So Youn Min; Tae Joo Kim; Young Joo Kim; Wilson Patrick; Ho-Youn Kim; Chandra Mohan
Journal:  Mol Immunol       Date:  2009-08-21       Impact factor: 4.407

Review 4.  Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus.

Authors:  Tony N Marion; Arnold E Postlethwaite
Journal:  Semin Immunopathol       Date:  2014-08-08       Impact factor: 9.623

5.  Molecular hallmarks of anti-chromatin antibodies associated with the lupus susceptibility locus, Sle1.

Authors:  Zhiyan Liang; Sooghee Chang; Min So Youn; Chandra Mohan
Journal:  Mol Immunol       Date:  2009-06-24       Impact factor: 4.407

6.  The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.

Authors:  Ian Giles; Nancy Lambrianides; David Latchman; Pojen Chen; Reginald Chukwuocha; David Isenberg; Anisur Rahman
Journal:  Arthritis Res Ther       Date:  2004-11-16       Impact factor: 5.156

Review 7.  The Anti-DNA Antibodies: Their Specificities for Unique DNA Structures and Their Unresolved Clinical Impact-A System Criticism and a Hypothesis.

Authors:  Ole Petter Rekvig
Journal:  Front Immunol       Date:  2022-01-11       Impact factor: 7.561

8.  Vaccination with minigenes encoding V(H)-derived major histocompatibility complex class I-binding epitopes activates cytotoxic T cells that ablate autoantibody-producing B cells and inhibit lupus.

Authors:  Guo-Chang Fan; Ram Raj Singh
Journal:  J Exp Med       Date:  2002-09-16       Impact factor: 14.307

9.  Short-term assessment of BCR repertoires of SLE patients after high dose glucocorticoid therapy with high-throughput sequencing.

Authors:  Bin Shi; Jiang Yu; Long Ma; Qingqing Ma; Chunmei Liu; Suhong Sun; Rui Ma; Xinsheng Yao
Journal:  Springerplus       Date:  2016-01-26

10.  Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas.

Authors:  Ole Petter Rekvig
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.